Abstract
What are the current challenges in improving outcome of muscle-invasive bladder cancer (MIBC) patients treated with radical radiotherapy. Which predictive biomarkers hold the potential to guide selection of patients suitable for bladder preservation? Are there clinically useful biomarkers to guide radiosensitizer selection? What promise does the combination of immunotherapy and radiotherapy hold in MIBC? How would the advances in technical radiotherapy improve tumour control while reducing toxicity of treatment?
Cite
CITATION STYLE
Joseph, N., Iype, R., & Choudhury, A. (2018). The future of radiotherapy in bladder cancer. In Treating Urothelial Bladder Cancer (pp. 123–129). Springer International Publishing. https://doi.org/10.1007/978-3-319-78559-2_16
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
